Maalox comprimate masticabile 400 mg + 400 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

maalox comprimate masticabile 400 mg + 400 mg

sanofi-aventis france - aluminii hydroxidum + magneziu hydroxidum - comprimate masticabile - 400 mg + 400 mg

Adcetris Uniunea Europeană - română - EMA (European Medicines Agency)

adcetris

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agenți antineoplazici - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.

EVEROLIMUS KRKA 10 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus krka 10 mg

synthon hispania, s.l. - spania - everolimus - compr. - 10mg - inhibitori de protein-kinaza inhibitor selectiv al mtor

EVEROLIMUS KRKA 2,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus krka 2,5 mg

synthon hispania, s.l. - spania - everolimus - compr. - 2,5mg - inhibitori de protein-kinaza inhibitor selectiv al mtor

EVEROLIMUS KRKA 5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus krka 5 mg

synthon hispania, s.l. - spania - everolimus - compr. - 5mg - inhibitori de protein-kinaza inhibitor selectiv al mtor

EVEROLIMUS MYLAN 10 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus mylan 10 mg

synthon hispania sl - spania - everolimus - compr. - 10mg - alte antineoplazice inhibitori de protein-kinaza

EVEROLIMUS MYLAN 2,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus mylan 2,5 mg

synthon hispania sl - spania - everolimus - compr. - 2,5mg - alte antineoplazice inhibitori de protein-kinaza

EVEROLIMUS MYLAN 5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

everolimus mylan 5 mg

synthon hispania sl - spania - everolimus - compr. - 5mg - alte antineoplazice inhibitori de protein-kinaza

PROFAST 10 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

profast 10 mg/ml

uab norameda - lituania - propofolum - emulsie inj./perf. - 10 mg/ml - anestezice generale alte anestezice generale

PROFAST 20 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

profast 20 mg/ml

uab norameda - lituania - propofolum - emulsie inj./perf. - 20 mg/ml - anestezice generale alte anestezice generale